Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
Humphrey L, Deffebach M, Pappas M, Baumann C, Artis K, Priest Mitchell J, Zakher B, Fu R, Slatore C
Record ID 32014000082
English
Authors' objectives:
To update the 2004 review of screening for lung cancer for the U.S. Preventive Services Task Force.
Authors' recommendations:
Good evidence shows LDCT can significantly reduce mortality from lung cancer. However, there are significant harms associated with screening that must be balanced with the benefits. More efforts to reduce false-positive examinations are of paramount importance and smoking cessation remains the most important approach to reducing lung cancer mortality.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.ncbi.nlm.nih.gov/books/NBK154610/pdf/TOC.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Mass Screening
- Lung Neoplasms
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.